Actively Recruiting

Age: 18Years - 65Years
FEMALE
NCT07202936

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Led by University of Bern · Updated on 2025-10-02

250

Participants Needed

1

Research Sites

151 weeks

Total Duration

On this page

Sponsors

U

University of Bern

Lead Sponsor

K

Krebsforschung Schweiz, Bern, Switzerland

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to improve cervical pre-cancer treatment outcomes among women living with HIV (WLWH), particularly in low and middle income countries (LMICs), by generating the evidence needed for post-treatment monitoring guidelines. The main questions it aims to answer are: * What is the risk of disease recurrence/persistence after cervical pre-cancer treatment among women living with HIV in Zimbabwe? * What is the predictive value of different human papillomavirus (HPV) and DNA methylation testing strategies for monitoring cervical disease recurrence/persistence after pre-cancer treatment? Participants will have cervical biopsies taken for histological assessment and cervical samples for HPV genotyping and DNA methylation testing. Researchers will follow all participating women every six months for 24 months to evaluate post-treatment monitoring and cervical disease outcomes.

CONDITIONS

Official Title

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Who Can Participate

Age: 18Years - 65Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18-65 years
  • Confirmed HIV positive status through medical records
  • Positive high-risk HPV genotype test at previous cervical cancer screening
  • Cervical pre-cancer treatment indicated by Newlands Clinic guidelines
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • History or suspicion of cervical cancer
  • History of total hysterectomy (no cervix)
  • Cervical pre-cancer treatment within the past 12 months
  • Currently pregnant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Women's Health Centre at Newlands Clinic

Harare, Zimbabwe

Actively Recruiting

Loading map...

Research Team

E

Eliane Rohner, MD, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here